Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Y. A. Efebera"'
Autor:
P. G. Richardson, C. C. Hofmeister, N. S. Raje, D. S. Siegel, S. Lonial, J. Laubach, Y. A. Efebera, D. H. Vesole, A. K. Nooka, J. Rosenblatt, D. Doss, M. H. Zaki, A. Bensmaine, J. Herring, Y. Li, L. Watkins, M. S. Chen, K. C. Anderson
Publikováno v:
Leukemia
This phase 1 dose-escalation study evaluated pomalidomide, bortezomib (subcutaneous (SC) or intravenous (IV)) and low-dose dexamethasone (LoDEX) in lenalidomide-refractory and proteasome inhibitor-exposed relapsed or relapsed and refractory multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3583d0256a39426910cc173ed97604d6
https://pubmed.ncbi.nlm.nih.gov/28642620
https://pubmed.ncbi.nlm.nih.gov/28642620
Autor:
Charles K. Allam, Saem Lee, Nikhil C. Munshi, Elizabeth Blanchard, Andrew J Han, Y. A. Efebera
Publikováno v:
Clinical lymphoma, myelomaleukemia. 11(3)
Necrobiotic xanthogranuloma (NXG) was first described in 1980 by Kossard and Winkelmann in an article in which they discussed 8 patients with xanthomatous plaques who were noted to have monoclonal gammopathy, predominantly of the Ig(immunoglobulin)G-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d24b4c1ce6bfd25b3aa5a06603360ca1
https://pubmed.ncbi.nlm.nih.gov/21658660
https://pubmed.ncbi.nlm.nih.gov/21658660
Autor:
Y. A. Efebera, Teresa G. Hayes, Alan Lichtenstein, Stephanie J. Lee, Terrence Grady, A. Han, Michal G. Rose, Abid Mohiuddin, Rao Prabhala, Mary Brophy, Paulette Mehta, Antoun Houranieh, Suman Kambhampati, Caroline Behler, G. D. Roodman, Abraham P. Zimelman, Nikhil C. Munshi, Christoph Klein
Publikováno v:
Journal of Clinical Oncology. 29:8074-8074
8074^ Background: The current BZ regimen administered twice a week for 2 weeks with one week off is effective, however is inconvenient and associated with toxicities such as neuropathy. To improve ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::063ccab857d12e41ff349b79001da2e3
https://doi.org/10.1200/jco.2011.29.15_suppl.8074
https://doi.org/10.1200/jco.2011.29.15_suppl.8074
Autor:
Mariateresa Fulciniti, Nithya Prabhala, Dheeraj Pelluru, YT Tai, K Lefkimmiatis, Puru Nanjappa, KC Anderson, John F. Daley, Rao Prabhala, C Mitsiaties, NC Munshi, Y. A. Efebera
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S159
Then focused on the RTK’s which were shown to be upregulated in WM and tested the effect of TKI-258 effect on their activity. Moreover, we tested the effect of TKI-258 survival, proliferation, and apoptosis of WM cells, and its effect of different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c6487ca455f6520ef7839e2f3d40b9b
https://doi.org/10.1016/s1557-9190(11)70795-8
https://doi.org/10.1016/s1557-9190(11)70795-8
Publikováno v:
Blood. 112:5210-5210
Necrobiotic xanthogranuloma (NXG) is a slowly progressive, destructive and infiltrating xanthomatous cutaneous lesions with plaques and is associated with monoclonal paraproteinemia, predominantly IgG. Here, we describe the first case of NXG associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ab817d50b0c979582d192f91c98e79e
https://doi.org/10.1182/blood.v112.11.5210.5210
https://doi.org/10.1182/blood.v112.11.5210.5210